Status:
COMPLETED
Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions:
Diabetic Nephropathy
Eligibility:
All Genders
14+ years
Phase:
PHASE3
Brief Summary
Hypothesis: The angiotensin receptor blocker telmisartan is effective at reduction of albumin excretion rate(AER) in patients with type1 diabetes and micro or macroalbuminuria. Dual blockade with the...
Detailed Description
To evaluate the antialbuminuric efficacy of an angiotensin receptor blocker (ARB) telmisartan and the combination of telmisartan and ramipril in patients with type1 DM and either micro or macroalbumin...
Eligibility Criteria
Inclusion
- Diabetes mellitus by ADA criteria
- Clinical history of DKA
- HbA1C \< 7.5,urine AER \>/= 20 mcg/min on two overnight urine samples
Exclusion
- Pregnancy
- Unwillingness to use contraception during time of study
- Creatinine \>3 mg/dl
- Suspected/proven non diabetic nephropathy
- Active urinary sediment
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00738660
Start Date
February 1 2007
End Date
May 1 2008
Last Update
August 20 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Post Graduate Institute of Medical Education and Research
Chandigarh, Chandigarh, India, 1600012